Construction of emergency management mode of pharmacy intravenous admixture under the background of COVID-19
10.3760/cma.j.cn111325-20200417-01127
- VernacularTitle:新冠肺炎背景下静脉用药集中调配应急管理模式构建
- Author:
Xiulan LIU
1
;
Lin QIU
;
Yi LIU
;
Pan LUO
;
Jingjin JIN
;
Jianling ZHENG
;
Xuepeng GONG
;
Dong LIU
;
Juan LI
Author Information
1. 华中科技大学同济医学院附属同济医院药学部，武汉 430030
- From:
Chinese Journal of Hospital Administration
2020;36(9):757-760
- CountryChina
- Language:Chinese
-
Abstract:
After the outbreak of COVID-19, due to environmental pollution in the isolated ward and operational constraints caused by protective clothing and other factors, intravenous drugs in the designated hospitals should be centralized. Combined with the existing process mode, the process of pharmacy intravenous admixture services was optimized, the operation mode of the operation platform was adjusted, the scheduling mechanism was optimized, and the node control process of " first verify and five checks" was explored and developed, so as to meet the 24 h needs of COVID-19 patients. According to the characteristics of COVID-19 drug treatment, the focus of prescription review was adjusted to ensure the drug safety of patients. Other measures included implementing paperless prescription to reduce unnecessary media; implementing segmented infusion distribution management to ensure no cross infection; hierarchical control and configuration environment, strengthening the protection and management of pharmacists, to avoid the risk of personnel infection; optimizing human resource allocation and improving work efficiency. This process reengineering and optimization established the emergency management mode of centralized intravenous drug deployment under the background of COVID-19, which ensured the intravenous drug demand and safety of COVID-19 patients. The treatment work was carried out orderly, and could provide reference for the pharmaceutical department in medical institutions to deal with major public health emergencies in the future.
